The Scientific Program will include the Plenary, Clinical Trials, Late-breaking Abstract sessions, as well as the popular Science Highlights and Cancer Breakthroughs session.
The Call for Abstracts for AM 2026 is now open and will close on February 24, 2026.
NEW for 2026!The Late-breaking Abstract (LBA) submission process is changing to ensure we are highlighting the very top science at every stage of planning. Late-breaking abstract shell submissions — placeholders for which no data are required — will be due on the regular submission deadline of February 24, 2026. Data for LBAs will be due on July 10, 2026. No results or conclusions are required for shell abstracts. Please review the abstract guidelines before starting your submission and mark your calendar for the key abstract deadlines below:
| ||||||||||||||||||